The downregulation of FAM111B in ovarian cancer cells resulted in a reduction in MYC expression levels; and subsequent rescue experiments revealed that the overexpression of MYC significantly affected the FAM111B phenotype, leading to the restoration of cellular viability, proliferation, migration, and invasion. The gene discussed is MYC; the disease is ovarian carcinoma.